Zobrazeno 1 - 10 of 74 pro vyhledávání: '"Maria H. Sjogren"'
1
Akademický článek
The management of HCV-infected pregnant women
Autor: Guillermo Valladares, Maria H. Sjogren, Alfonso Chacaltana
Publikováno v: Annals of Hepatology, Vol 9, Iss , Pp S92-S97 (2010)
Hepatitis C is, at present, a worldwide health problem and is the most common cause of liver transplantation. Its prevalence in pregnant women is similar to that of the general population. In the absence of cirrhosis and portal hypertension, most HCV
Externí odkaz: https://doaj.org/article/df818399ffb4437786bc7a7d94eec767
Zobrazit plný text záznamu
5
Significance of IgM antibody to hepatitis B core antigen in a Greek population with chronic hepatitis B virus infection
Autor: George Papaevangelou, Nicolaos C. Tassopoulos, Ronald E. Engle, Anastasia Roumeliotou-Karayannis, John R. Ticehurst, Maria H. Sjogren, John L. Gerin, Robert H. Purcell
Publikováno v: Liver. 6:275-280
IgM antibody to hepatitis B core antigen (IgM anti-HBc) may indicate an active immune response to persistent infection with hepatitis B virus (HBV). We studied 186 Greek HBsAg carriers for IgM anti-HBc and attempted to correlate it with other HBV and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87a4c1139f2880448624d31c238b48f2
https://doi.org/10.1111/j.1600-0676.1986.tb00291.x
Zobrazit plný text záznamu
6
Thymosin beta4 Upregulates the Expression of Hepatocyte Growth Factor and Downregulates the Expression of PDGF-beta Receptor in Human Hepatic Stellate Cells
Autor: Elena Barnaeva, Agladze Nadezhda, Maria H. Sjogren, Ewald Hannappel, Marcos Rojkind
Publikováno v: Annals of the New York Academy of Sciences. 1112:154-160
Hepatic stellate cells (HSCs) are the main producers of type I collagen in the liver, and therefore are responsible, in part, for the fibrous scar observed in cirrhotic livers. Although there is no approved treatment for this deadly disease, drugs in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63113c3b51454d4de38ac882bda25473
https://doi.org/10.1196/annals.1415.035
Zobrazit plný text záznamu
7
Interferon Alfacon-1 and Ribavirin Versus Interferon ?-2b and Ribavirin in the Treatment of Chronic Hepatitis C
Autor: Milton T. Smith, Amber Watts, Robert W. Sjogren, Maria H. Sjogren, Kent C. Holtzmuller, Robin S. Howard, Bradley J. Winston, Betty Butterfield, Stanley Drake
Publikováno v: Digestive Diseases and Sciences. 50:727-732
Despite advances in the therapy of chronic hepatitis C, a large number of patients do not respond to current therapies. The study objective was to assess whether a combination of interferon (IFN) alfacon-1 and ribavirin improves the response rate com
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c44bc0dbaebcaf53f7175638d5e029e
https://doi.org/10.1007/s10620-005-2564-2
Zobrazit plný text záznamu
9
Hepatitis C in Peru: risk factors for infection, potential iatrogenic transmission, and genotype distribution
Autor: Jose L. Sanchez, Maria H. Sjogren, Niel T. Constantine, Mohamed Abdel-Hamid, Douglas M. Watts, Johnny D. Callahan, Carmen Lucas, Judith C. Cuthie, Rolando Figueroa-Barrios, Santos Hinostroza, Kenneth C. Hyams
Publikováno v: The American Journal of Tropical Medicine and Hygiene. 63:242-248
A large seroepidemiologic and genotyping study of hepatitis C virus (HCV) was conducted in Lima, Peru, during the periods of 1986 to 1993 (cohort A) and 1994 (cohort B). Anti-HCV seroprevalence rates were 15.6% (216 of 1,389) and 11.7% (168 of 1,438)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9f65f2da9cf4c25714d4ee7deb58ca7a
https://doi.org/10.4269/ajtmh.2000.63.242
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje